Red yeast rice (RYR) is ann over-the-counter alternative for lowering LDL cholesterol. It's made by fermenting white rice with a yeast called Monascus purpureus, and the fermentation produces a family of compounds called monacolins, the most important being monacolin K, which is structurally identical to the prescription statin lovastatin. If your bloodwork shows elevated LDL and you either can't tolerate statins, don't want to go the prescription route yet, RYR is the single most studied and most effective natural option available.

• deep dive

Product quality is the single biggest practical issue with RYR. Because it's sold as a supplement, not a drug, there's no standardization. Studies have found up to 100-fold variation in monacolin content between brands. Some products contain virtually no active compound. Worse, many products are contaminated with citrinin, a nephrotoxic mycotoxin produced during fermentation. An analysis of 37 RYR products found that only one had citrinin levels below the EU safety limit, and four products labeled "citrinin-free" still tested positive. This is not a minor concern. If you're going to use RYR, buy from manufacturers who provide third-party certificates of analysis confirming both monacolin K content and citrinin testing. Thorne and other reputable supplement brands test for citrinin and standardize monacolin content.

CoQ10 depletion is a real consideration. Because monacolin K inhibits HMG-CoA reductase, it also reduces synthesis of coenzyme Q10 downstream in the same pathway. CoQ10 is essential for mitochondrial energy production, and depletion can contribute to muscle fatigue, weakness, and potentially the myalgia that makes people stop statins. Co-supplementing with 100-200mg of CoQ10 daily is standard practice when using any HMG-CoA reductase inhibitor, and RYR is no exception.

Dosage:

• Standard cholesterol-lowering dose: 1,200-2,400mg of RYR daily, taken in divided doses (600-1,200mg twice daily with meals). The goal is to deliver 5-10mg of monacolin K per day, which is the dose range supported by the majority of clinical trials
• Lower dose / maintenance: 600-1,200mg daily (delivering roughly 3-5mg monacolin K). The EU has capped monacolin K at 3mg/day for supplements, which still shows meaningful LDL reduction in trials but is more conservative. Reasonable for mild dyslipidemia or as ongoing maintenance
• No sex-specific dose adjustment needed. Women respond at least as well as men at equivalent doses
• Always take with food, preferably with dinner or an evening meal. Cholesterol synthesis peaks overnight, so evening dosing aligns with the body's production cycle and improves absorption of the fat-soluble monacolins
• Always co-supplement with CoQ10 (100-200mg daily) to offset downstream depletion from HMG-CoA reductase inhibition
• Product selection matters more than dose. Only buy RYR from brands that explicitly state the monacolin K content per dose on the label. If the label only lists "red yeast rice 1,200mg" without specifying monacolin K, you have no idea whether you're getting an active product or expensive rice powder. Many US products have been reformulated to contain little or no monacolin K due to FDA pressure (the FDA considers monacolin K an unapproved drug). Look for products that disclose monacolin K per serving and provide third-party certificates of analysis confirming both monacolin K content and absence of citrinin
• Do not combine with prescription statins, gemfibrozil, niacin at high doses, cyclosporine, or CYP3A4 inhibitors (certain antibiotics, antifungals, grapefruit juice). The drug interaction profile is identical to lovastatin

Here's what you can expect:

If your LDL is elevated and you start a quality RYR product at 1,200-2,400mg daily, you should see measurable LDL reduction on bloodwork within 6-8 weeks, typically 15-25% depending on your starting levels and the monacolin K content of your product. Total cholesterol and triglycerides will likely drop as well. Some people see reductions as high as 30-35% at 12 months. If you're using it to manage cycle-induced lipid damage, expect partial improvement, not full normalization, especially if you're still running compounds. The effects are dose-dependent and product-dependent, so if you see no change after 8 weeks, your product may contain insufficient monacolin K. Switch brands and retest. Don't expect to "feel" anything. Unlike some supplements, RYR doesn't produce subjective effects. The benefit is entirely in your bloodwork and long-term cardiovascular risk.

Side effects & risks:

• Muscle pain (myalgia) is the most discussed side effect, because RYR contains the same active compound as lovastatin. In practice, the incidence at typical RYR doses (3-10mg monacolin K) is low, with meta-analyses showing no significant difference from placebo. But it can happen, especially at higher doses or in people with prior statin intolerance. If you develop unexplained muscle pain, weakness, or dark urine, stop immediately and get CK levels checked
• Liver enzyme elevation can occur, as with any statin. Most cases are mild and reversible, but severe hepatotoxicity has been reported in rare cases. Don't combine with other hepatotoxic compounds (alcohol, certain medications) without monitoring. Get baseline liver function tests before starting and recheck at 8-12 weeks